Does It Pay To Know An Academy Member?

Since January 1996, manuscript submission to Proceedings of the National Academy of Sciences has been changed to three tracks: an academy member may "communicate" manuscripts for others that are within the member's area of expertise; authors may submit their manuscripts directly to the Proceedings office and the office will choose an academy member to "edit" the manuscripts; an academy member may "contribute" his or her own manuscripts for publication. The manuscripts submitted through

Written byShibo Jiang
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Since January 1996, manuscript submission to Proceedings of the National Academy of Sciences has been changed to three tracks:

The manuscripts submitted through Tracks I and II are reviewed by qualified referees selected by "communicator" members and "editor" members, respectively, while those submitted through Track III are reviewed by a knowledgeable colleague of the "contributor" member prior to the submission.

This change has benefited authors who do not know or have no connection with academy members, since they can directly submit their manuscripts to the Proceedings through Track II. But one may ask whether a manuscript is published faster if the author knows the member-editor.

To answer this question, I checked three issues of the Proceedings (Vol. 95, Nos. 1 to 3, published on January 6, January 20, and February 3, 1998, respectively) and counted the number of days from submission to publication of a manuscript. The result indicates that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies